Home › Lipid Metabolism Disorders › NCT05693701

Multicomponent Intervention Study- Blood Donors With High Cholesterol

Implementing a Multicomponent Intervention to Treat Blood Donors With Familial Hypercholesterolemia

Who can join

Ages 18 to 75 · All sexes

Inclusion Criteria:

* Blood donors from Carter BloodCare with high cholesterol meeting MEDPED FH criteria
* Age 18 to 75 years

Exclusion Criteria:

* Currently taking medication to lower cholesterol
* Taking any medication that can interact with statins
* Pregnancy
* Identified secondary cause of elevated lipids
* Chronic liver disease or significantly elevated liver function tests (\> 3 times upper limit)

About the study

The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).

What is being tested

• Implementation Strategy Bundle (behavioral)
• Usual care notification (other)

Sponsor: University of Texas Southwestern Medical Center · Participants: 100 · Started: Feb 27, 2023

Contact the study team

• Amit Khera, MD · Phone: 214.645.7500
• Lakeisha Cade · Phone: 214.648.2878

Official record on ClinicalTrials.gov — NCT05693701

Locations in the U.S.

Conditions

• Lipid Metabolism Disorders
• Cholesterol

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.